Identifying and Validating New Drug Targets for Stroke and Beyond: Can Mendelian Randomization Help?

Affiliations

¹ Takeda Pharmaceutical Company Limited, Cambridge, MA (A.P.).
² Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom (G.D.S.).

Editorial

Andrew Plump et al. Circulation. 2019.

. 2019 Sep 9;140(10):831-835.

doi: 10.1161/CIRCULATIONAHA.119.042005. Epub 2019 Sep 3.

¹ Takeda Pharmaceutical Company Limited, Cambridge, MA (A.P.).
² Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom (G.D.S.).

No abstract available

Keywords: Editorials; Mendelian randomization analysis; drug discovery; stroke.

Comment on

Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome.
Chong M, Sjaarda J, Pigeyre M, Mohammadi-Shemirani P, Lali R, Shoamanesh A, Gerstein HC, Paré G. Chong M, et al. Circulation. 2019 Sep 9;140(10):819-830. doi: 10.1161/CIRCULATIONAHA.119.040180. Epub 2019 Jun 18. Circulation. 2019. PMID: 31208196